Page 19 - Research Models News Today

-- Inotiv has an average buy rating and price target range of $7.25 to $34, according to analysts polled by Capital IQ. Price: 5.43, Change: +0.36, Percent Change: +7.15 ...

Inotiv, Inc. (NASDAQ:NOTV – Get Free Report) was the target of a significant decrease in short interest in June. As of June 30th, there was short interest totalling 1,360,000 shares, a decrease of 33.0% from the June 15th total of 2,030,000 shares. Based on an average daily trading volume, of 379,900 shares, the days-to-cover ratio […]

RADNOR, Pa. , July 17, 2023 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities...

/PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been against...

The report "Biologics Safety Testing Market by Product & Service (Instruments, Consumables, Services), Application (mAbs, Vaccine, Cell & Gene Therapy), Test Type (Sterility Test, Endotoxin, Mycoplasma, Bioburden), End User (Biopharma, CDMO) - Global Forecast to 2027

Deadline in 5 Days for Charles River Laboratories International, Inc. ...

Sonic Healthcare (OTCMKTS:SKHCF – Get Free Report) and Charles River Laboratories International (NYSE:CRL – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, analyst recommendations, profitability, risk and dividends. Earnings & Valuation This table compares […]

Citigroup downgraded shares of Charles River Laboratories International (NYSE:CRL – Free Report) from a buy rating to a neutral rating in a research report released on Monday morning, Marketbeat reports. Citigroup currently has $225.00 price objective on the medical research company’s stock, down from their previous price objective of $260.00. Several other research analysts have […]

Sonic Healthcare (OTCMKTS:SKHCF – Get Free Report) and Charles River Laboratories International (NYSE:CRL – Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation and dividends. Insider & Institutional Ownership 31.8% of […]

Eagle Bay Advisors LLC cut its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 6.6% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 780 shares of the medical research company’s stock after selling 55 shares during the quarter. Eagle […]